2016-04-28 20:21:14 UTC

Ulcerative Colitis

Chicago, IL.

Duration

32:53

About

Review of treatments for Ulcerative Colitis:

Download the session audio:

MP3 File

Download the PowerPoint presentation:

PPT File

About the Instructors

David Rubin, MD, AGAF

David T. Rubin earned a medical degree with honors at the University of Chicago Pritzker School of Medicine. He completed his residency in internal medicine and fellowships in gastroenterology and clinical medical ethics at the University of Chicago, where he served as Chief Resident and Chief Fellow. Prior to his current appointments, Dr. Rubin served for 11 years as Director of the Gastroenterology, Hepatology and Nutrition fellowship program. He also currently serves as an associate faculty member at the MacLean Center for Clinical Medical Ethics and an associate investigator at the University of Chicago Comprehensive Cancer Center.  Dr. Rubin is a Fellow of the American Gastroenterological Association, the American College of Gastroenterology (ACG), the American Society for Gastrointestinal Endoscopy and the American College of Physicians and an active national member of the Crohn’s & Colitis Foundation of America (CCFA), and is on the Board of Trustees for the ACG. Among numerous awards and honors, Dr. Rubin was chosen by his peers as a member of Best Doctors (recognized for superior clinical ability) and America’s Top Physicians (gastroenterology). Additionally, he twice received the ACG’s Governor’s Award of Excellence in Clinical Research (2003 and 2013), the Cancer Research Foundation Young Investigator’s Award (2004), and the UC Postgraduate Teaching Award in recognition of significant contributions for fellowship education (2006). In 2012, he received the CCFA’s Rosenthal Award, a national leadership award bestowed upon a volunteer who has contributed in an indisputable way to the quality of life of patients and families.  Dr. Rubin is the editor of a best-selling book on inflammatory bowel disease (IBD), now in its 2nd edition, and an author or coauthor of many peer-reviewed articles on IBD, genetic testing in IBD, and cancer in IBD. He is also a featured media contact for issues related to IBD, appearing on satellite radio, television, and print media. His principal research interests include novel IBD therapies and outcomes, colon cancer prevention, and clinical medical ethics. 

More on Ulcerative Colitis

Association Between Low Trough Levels of Vedolizumab During Induction Therapy for Inflammatory Bowel Diseases and Need for Additional Doses Within 6 Months

Oct. 22, 2017

We investigated whether serum trough levels of vedolizumab, during the induction phase can determine whether patients need additional doses within 6 months.

How Will Translational Advances in Pediatric IBD Affect Practices?

Oct. 17, 2017

Dr. Rosen will discuss how new findings can make a difference for pediatric IBD patients at the Crohn’s & Colitis Congress.

Blog: Special 15th Anniversary Collection from Clinical Gastroenterology and Hepatology

Oct. 11, 2017

Celebrate this milestone with a look back at landmark articles, commentaries and reviews. Read more on the AGA Journals blog.